FBR Announces Second Annual Healthcare Conference

20:00 EDT 4 Aug 2015 | Globe Newswire

ARLINGTON, Va., Aug. 5, 2015 (GLOBE NEWSWIRE) -- FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced its Second Annual Healthcare Conference. The event will be held on Wednesday, September 9, 2015 at the Four Seasons Hotel in Boston, Massachusetts.

This unique conference brings corporate executives and institutional investors together for a day of one-on-one discussions on the future of the healthcare industry. Participants will discuss the strategy and outlook of specific companies as well as emerging themes across the healthcare industry. Over 60 companies, including public and private entities across the spectrum and including biotechnology, healthcare IT, managed care, pharmaceutical services and clinical labs.

Cardinal Health, Inc. Chairman and Chief Executive Officer George Barrett will be the keynote speaker and will discuss the emerging industry trends and how they will impact healthcare. Mr. Barrett is a 30 year veteran of the healthcare industry. Prior to joining Cardinal in 2008, Mr. Barrett served in a number of positions at Teva Pharmaceuticals, most recently as the President and CEO of North America for Teva Pharmaceutical Industries. He serves on the board of directors for Nationwide Children's Hospital and the boards of trustees of the Healthcare Leadership Council and the Conference Board and is a member of the Business Roundtable.

"Our inaugural healthcare conference last year was extremely successful and we have been encouraged by institutional investors, as well as corporate clients, to make this an annual event," offered FBR Executive Vice President and Head of Investment Banking Kenneth Slosser. "In fact, with over 70 companies currently attending, we have seen a year-over-year increase of 64% in the number of management teams participating in this event.  We look forward to building on our tradition of delivering a valuable industry-specific conference."

"In the tradition of FBR's proprietary research approach, The DebateTM, this conference will give investors the opportunity to participate in timely, in-depth conversations around the core issues facing the healthcare companies today," said Senior Managing Director and Director of Research David Hilal.  "These conversations will examine the drivers of change, innovation and the delivery of healthcare products and services within the global context and how market leading companies are addressing these realities."

Registration is required for attendance. For more information about this conference, including the complete schedule and list of participating companies, as well as registration, please visit,

FBR & Co. (Nasdaq:FBRC) provides investment banking, merger and acquisition advisory, institutional brokerage, and research services through its subsidiary FBR Capital Markets & Co. FBR focuses capital and financial expertise on the following industry sectors: consumer; energy & natural resources; financial institutions; healthcare; industrials; insurance; real estate; and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices throughout the United States. For more information, please visit

         Shannon Hawkins
         at 703.469.1190
         Linda E. Eddy
         at 703.312.9715

FBR & Co.


More From BioPortfolio on "FBR Announces Second Annual Healthcare Conference"

Quick Search


Relevant Topics

Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...